As grid instability and electricity price volatility reshape European energy demands, lithium-ion battery supplier Ampace is arriving at Intersolar Europe 2026 to launch two flagship storage systems. The company aims to bridge supply gaps for both industrial facilities and private households through its new UniC AG440 and PR-S3 Elite units.
From July through October, Shanghai will transform into a sprawling hub of culture and commerce as the 2026 Shanghai Summer International Consumption Season kicks off. Centered on the theme "Join the Family Fun," the initiative spans everything from elite sporting tournaments to museum showcases, aiming to draw both locals and global travelers.
Akeso has officially launched its Phase Ib/II clinical study of AK138D1, a next-generation HER3-targeting antibody-drug conjugate, marking a new phase in the company’s effort to combine advanced immunotherapy with targeted delivery for patients with advanced breast cancer.
Between June 8 and June 12, 2026, Ericsson repurchased 2.7 million Class B shares, marking a significant step in its ongoing 15 billion SEK buyback program. The transactions, executed via Goldman Sachs on Nasdaq Stockholm, brought the company's total treasury holdings to 53,076,778 shares.
Nearly one-third of America's rural hospitals currently face the threat of closure, leaving small-town populations at risk of losing primary healthcare access. North Canyon Medical Center, an Idaho-based network, is partnering with the series 'All Access Hosted by Andy Garcia' to demonstrate how technological agility can secure these vital institutions.
Between June 8 and June 12, 2026, Ericsson acquired 2.7 million of its own Class B shares on Nasdaq Stockholm. The transactions, valued at approximately 308.9 million SEK, represent a significant phase in the telecommunications giant's ongoing 15 billion SEK capital return program scheduled to conclude by March 2027.
Atmospheric chemist Susan Solomon has been awarded the 2026 Tang Prize in Sustainable Development, a distinction recognizing her foundational role in identifying the causes of ozone depletion and shaping international climate policy. The award, which includes a NT$50 million grant, honors four decades of research into Earth’s atmospheric chemistry.
Germany-based Brenntag has secured the top spot in the 17th annual ICIS Top 100 Chemical Distributors list, reporting $17.8 billion in 2025 sales. The ranking highlights the critical role of distribution firms in maintaining supply chain stability amid ongoing geopolitical instability and shifting market demands across global chemical sectors.
Rising veterinary expenses force many owners into impossible choices, often prioritizing their bank accounts over animal welfare. To address this, Pet Insurance Quotes has partnered with the educational series "Empowered hosted by Meg Ryan," aiming to demystify complex insurance policies and help owners navigate the marketplace before emergencies strike.
Mitsubishi Fuso Truck and Bus Corporation has officially adopted Clarivate’s IPfolio to overhaul its intellectual property management. By consolidating patents and trademarks into a single cloud-based interface, the manufacturer aims to replace manual verification processes with automated data enrichment and real-time portfolio visibility across its engineering divisions.
Milan-based Tethis S.p.A. has released an application note detailing a new workflow for multiplex immunofluorescence imaging of non-adherent cells. By utilizing nanostructured titanium dioxide coatings, the company addresses long-standing challenges in retaining suspension-derived samples, such as PBMCs, through repeated staining and signal-erasure cycles on spatial biology platforms.
With summer temperatures rising, JIMMY has brought its Matrix Series to the European market, transforming the standard countertop reverse osmosis purifier into a multifunctional home bar. The M9 Pro system introduces detachable S9 and I9 modules, allowing users to produce chilled sparkling water and crushed ice alongside purified hot water.
Shareholders who acquired Calix, Inc. stock between January 28 and April 21, 2026, face a critical deadline to join a pending class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging that the company misled the market regarding its financial health and procurement strategies during that period.
Investors who purchased Zoetis Inc. stock between January 14, 2025, and May 6, 2026, are being urged to join a class action lawsuit filed against the pharmaceutical company. The litigation alleges that the firm violated federal securities laws by issuing false statements regarding the performance of its core product lines.
A class action lawsuit filed against Sportradar Group AG alleges the company misled shareholders by inflating revenue through partnerships with illegal gambling organizations. The litigation, centered on violations of the Securities Exchange Act, claims the firm’s internal compliance and Know-Your-Customer protocols failed to meet publicly stated standards.
Investors who purchased Veritone, Inc. securities between October 14, 2025, and April 14, 2026, are being urged to join a class action lawsuit filed by the Schall Law Firm. The litigation centers on claims that the company misled the market by misclassifying revenues and failing to maintain proper financial controls.
Investors who purchased Sportradar Group AG securities between November 7, 2024, and April 21, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders by claiming strict regulatory compliance while reportedly engaging with black-market gambling organizations during the period.
Shareholders who purchased Phreesia, Inc. stock between May 8, 2025, and March 30, 2026, are being sought by the Schall Law Firm to join a class action lawsuit. The litigation alleges the company misled investors regarding its long-term growth outlook and the stability of its fiscal year 2027 revenue projections.
Investors who held FS KKR Capital Corp. stock between May 8, 2024, and February 25, 2026, are facing a legal deadline as a class action lawsuit moves forward. The litigation targets alleged violations of the Securities Exchange Act, centered on claims that the firm misled shareholders regarding its portfolio valuation.
More than 60 athletes have punched their tickets to the Games of the Future 2026 following five intense days of competition in Astana. The Phygital Contenders event saw over 200 participants from 20 countries push the boundaries of hybrid sport, blending digital precision with high-stakes physical performance in three distinct disciplines.
A class action lawsuit has been filed against Calix, Inc., accusing the telecommunications equipment provider of misleading shareholders about its financial health. The litigation centers on claims that the company inflated its first-quarter performance by masking the true impact of surging memory module costs.
Investors who purchased SES AI Corporation securities between January 29, 2025, and March 4, 2026, are being called to join a class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging that the company misled the market through deceptive financial reporting and inflated partnership claims.
Investors who held shares in FS KKR Capital Corp. between May 8, 2024, and February 25, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders regarding its portfolio valuation, restructuring effectiveness, and the long-term stability of its dividend program.
Investors who purchased Graphic Packaging Holding Company stock between February 4, 2025, and February 2, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders regarding internal inventory struggles and weakening demand, leading to significant financial losses when the reality surfaced.
Investors who purchased POET Technologies stock between April 1 and April 27, 2026, face potential financial losses following a class action lawsuit filed by the Schall Law Firm. The legal action alleges that the company violated federal securities laws by misrepresenting its tax status and internal business conduct.
Investors who purchased Immutep Limited shares between March 24, 2025, and March 12, 2026, are being urged to join a class action lawsuit. The litigation alleges the company misled shareholders regarding the efficacy of its TACTI-004 clinical trial for the drug eftilagimod alfa.
Investors who purchased POET Technologies shares between April 1 and April 27, 2026, face a critical window to join a class action lawsuit. The DJS Law Group is currently organizing plaintiffs to address allegations that the company misled the market regarding its tax status as a passive foreign investment entity.
Investors who purchased Commvault Systems stock between April 29, 2025, and January 26, 2026, are being urged to join a class action lawsuit against the company. The Schall Law Firm alleges that Commvault misled the market regarding its annual recurring revenue growth during that period, causing significant financial losses.
Investors who purchased Immutep Limited securities between March 24, 2025, and March 12, 2026, face a critical window to join a class action lawsuit against the company. The Schall Law Firm is spearheading the litigation, alleging that the biotech firm misled shareholders regarding the results of its TACTI-004 clinical trial.
Investors who purchased Graphic Packaging Holding Company stock between February 4, 2025, and February 2, 2026, are facing a legal deadline of July 6, 2026, to join a class action lawsuit alleging the firm misled the market regarding inventory management, operational costs, and declining consumer demand.
